Business Description
Bioton SA
ISIN : PLBIOTN00029
Total Employee Number:
363Description
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 1.11 | |||||
Interest Coverage | 2.86 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | -0.4 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 2.8 | |||||
3-Year EPS without NRI Growth Rate | -8.4 | |||||
3-Year FCF Growth Rate | -28.9 | |||||
3-Year Book Growth Rate | -0.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.31 | |||||
9-Day RSI | 43.22 | |||||
14-Day RSI | 42.01 | |||||
3-1 Month Momentum % | -6.31 | |||||
6-1 Month Momentum % | -1.29 | |||||
12-1 Month Momentum % | -3.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 195.96 | |||||
Days Sales Outstanding | 44.32 | |||||
Days Payable | 61.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 0.74 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.78 | |||||
Operating Margin % | 5.41 | |||||
Net Margin % | 1.52 | |||||
EBITDA Margin % | 19.86 | |||||
FCF Margin % | 1.59 | |||||
OCF Margin % | 6.18 | |||||
ROE % | 0.69 | |||||
ROA % | 0.53 | |||||
ROIC % | 0.27 | |||||
3-Year ROIIC % | 3.51 | |||||
ROC (Joel Greenblatt) % | 4.05 | |||||
ROCE % | 2.15 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 83.18 | |||||
PE Ratio without NRI | 72.59 | |||||
PS Ratio | 1.29 | |||||
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 1.29 | |||||
Price-to-Free-Cash-Flow | 79.85 | |||||
Price-to-Operating-Cash-Flow | 20.91 | |||||
EV-to-EBIT | 27.91 | |||||
EV-to-EBITDA | 7.42 | |||||
EV-to-Revenue | 1.47 | |||||
EV-to-FCF | 93.79 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 0.58 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Graham-Number | 2.04 | |||||
Earnings Yield (Greenblatt) % | 3.59 | |||||
FCF Yield % | 1.26 | |||||
Forward Rate of Return (Yacktman) % | -3.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioton SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 61.701 | ||
| EPS (TTM) (€) | 0.011 | ||
| Beta | 0.2863 | ||
| 3-Year Sharpe Ratio | 0.14 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 34.44 | ||
| 14-Day RSI | 42.01 | ||
| 14-Day ATR (€) | 0.008921 | ||
| 20-Day SMA (€) | 0.8815 | ||
| 12-1 Month Momentum % | -3.77 | ||
| 52-Week Range (€) | 0.852 - 1.15 | ||
| Shares Outstanding (Mil) | 85.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioton SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioton SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioton SA Frequently Asked Questions
What is Bioton SA(FRA:7U5)'s stock price today?
The current price of FRA:7U5 is €0.88. The 52 week high of FRA:7U5 is €1.15 and 52 week low is €0.85.
When is next earnings date of Bioton SA(FRA:7U5)?
The next earnings date of Bioton SA(FRA:7U5) is .
Does Bioton SA(FRA:7U5) pay dividends? If so, how much?
Bioton SA(FRA:7U5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bioton SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers